- ONCT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Oncternal Therapeutics (ONCT) 10-K/A2018 FY Annual report (amended)
Filed: 30 Apr 19, 4:45pm
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, Marc S. Hanover, certify that:
Date: April 30, 2019 | ||
/s/ Marc S. Hanover Marc S. Hanover Chief Executive Officer |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.